270 related articles for article (PubMed ID: 32398224)
1. Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.
Nathani P; Gopal P; Rich N; Yopp A; Yokoo T; John B; Marrero J; Parikh N; Singal AG
Gut; 2021 Feb; 70(2):401-407. PubMed ID: 32398224
[TBL] [Abstract][Full Text] [Related]
2. Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
Kim JK; Kim HD; Jun MJ; Yun SC; Shim JH; Lee HC; Lee D; An J; Lim YS; Chung YH; Lee YS; Kim KM
Dig Dis Sci; 2017 Oct; 62(10):2923-2931. PubMed ID: 28815349
[TBL] [Abstract][Full Text] [Related]
3. Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias.
Toyoda H; Kumada T; Tada T; Mizuno K; Hiraoka A; Tsuji K; Ishikawa T; Akita T; Tanaka J
Liver Int; 2018 Dec; 38(12):2260-2268. PubMed ID: 29981527
[TBL] [Abstract][Full Text] [Related]
4. Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease.
An C; Choi YA; Choi D; Paik YH; Ahn SH; Kim MJ; Paik SW; Han KH; Park MS
Clin Mol Hepatol; 2015 Sep; 21(3):279-86. PubMed ID: 26523271
[TBL] [Abstract][Full Text] [Related]
5. Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time.
Shingaki N; Tamai H; Mori Y; Moribata K; Enomoto S; Deguchi H; Ueda K; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
Mol Clin Oncol; 2013 Nov; 1(6):977-981. PubMed ID: 24649280
[TBL] [Abstract][Full Text] [Related]
6. Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging.
Taouli B; Goh JS; Lu Y; Qayyum A; Yeh BM; Merriman RB; Coakley FV
J Comput Assist Tomogr; 2005; 29(4):425-9. PubMed ID: 16012295
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis.
Rich NE; John BV; Parikh ND; Rowe I; Mehta N; Khatri G; Thomas SM; Anis M; Mendiratta-Lala M; Hernandez C; Odewole M; Sundaram LT; Konjeti VR; Shetty S; Shah T; Zhu H; Yopp AC; Hoshida Y; Yao FY; Marrero JA; Singal AG
Hepatology; 2020 Nov; 72(5):1654-1665. PubMed ID: 32017165
[TBL] [Abstract][Full Text] [Related]
8. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
Huang YH; Park BV; Chen YF; Gaba RC; Guzman G; Lokken RP
J Vasc Interv Radiol; 2019 Sep; 30(9):1317-1324. PubMed ID: 31375450
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the natural growth rate of hepatocellular carcinoma: A real-world retrospective study in southwestern China.
Tu L; Xie H; Li Q; Lei PG; Zhao PL; Yang F; Gong C; Yao YL; Zhou S
World J Hepatol; 2024 May; 16(5):800-808. PubMed ID: 38818290
[TBL] [Abstract][Full Text] [Related]
10. Tumour volume doubling time of molecular breast cancer subtypes assessed by serial breast ultrasound.
Ryu EB; Chang JM; Seo M; Kim SA; Lim JH; Moon WK
Eur Radiol; 2014 Sep; 24(9):2227-35. PubMed ID: 24895040
[TBL] [Abstract][Full Text] [Related]
11. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Kim TY; Lee JH; Kim WB; Shong YK; Chung KW; Baek JH; Kim WG
Thyroid; 2019 May; 29(5):642-649. PubMed ID: 30864894
[No Abstract] [Full Text] [Related]
12. Effect of alcohol on tumor growth of hepatocellular carcinoma with type C cirrhosis.
Matsuhashi T; Yamada N; Shinzawa H; Takahashi T
Intern Med; 1996 Jun; 35(6):443-8. PubMed ID: 8835593
[TBL] [Abstract][Full Text] [Related]
13. Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.
Villa E; Critelli R; Lei B; Marzocchi G; Cammà C; Giannelli G; Pontisso P; Cabibbo G; Enea M; Colopi S; Caporali C; Pollicino T; Milosa F; Karampatou A; Todesca P; Bertolini E; Maccio L; Martinez-Chantar ML; Turola E; Del Buono M; De Maria N; Ballestri S; Schepis F; Loria P; Enrico Gerunda G; Losi L; Cillo U
Gut; 2016 May; 65(5):861-9. PubMed ID: 25666192
[TBL] [Abstract][Full Text] [Related]
14. Determining Whether Tumor Volume Doubling Time and Growth Rate Can Predict Malignancy After Delayed Diagnostic Surgery of Follicular Neoplasm.
Kim M; Chung SR; Jeon MJ; Han M; Lee JH; Song DE; Baek JH; Kim TY; Kim WB; Shong YK; Kim WG
Thyroid; 2019 Oct; 29(10):1418-1424. PubMed ID: 31375058
[No Abstract] [Full Text] [Related]
15. Intranodular blood supply correlates well with biological malignancy grade determined by tumor growth rate in pathologically proven hepatocellular carcinoma.
Kudo M; Tochio H
Oncology; 2008; 75 Suppl 1():55-64. PubMed ID: 19092273
[TBL] [Abstract][Full Text] [Related]
16. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up.
Furlan A; Marin D; Agnello F; Di Martino M; Di Marco V; Lagalla R; Catalano C; Brancatelli G
J Comput Assist Tomogr; 2012; 36(1):20-5. PubMed ID: 22261766
[TBL] [Abstract][Full Text] [Related]
18. Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy.
Saraiya N; Yopp AC; Rich NE; Odewole M; Parikh ND; Singal AG
Aliment Pharmacol Ther; 2018 Jul; 48(2):127-137. PubMed ID: 29851093
[TBL] [Abstract][Full Text] [Related]
19. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
[TBL] [Abstract][Full Text] [Related]
20. Stochastic modeling of the tumor volume assessment and growth patterns in hepatocellular carcinoma.
Sãftoiu A; Ciurea T; Gorunescu F; Rogoveanu I; Georgescu C
Bull Cancer; 2004 Jun; 91(6):E162-6. PubMed ID: 15562561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
